Category: Claim Reviews

HealthWatchlist verdict: Oregano oil has activity against Borrelia in laboratory cultures. The research identified here does not establish that it treats Lyme disease in people, reaches an effective safe concentration in the body or resolves persistent symptoms.

What did the widely shared experiment find?

Feng and colleagues screened 34 essential oils in 2017. The experiments used stationary-phase cultures of Borrelia burgdorferi, including forms that can tolerate antibiotics under laboratory conditions.

Oregano, cinnamon bark and clove bud oils were among the strongest performers. Under the tested conditions, cultures exposed to these oils did not regrow during subsequent subculture. Carvacrol was an active oregano component; other tested components did not show the same activity.

These are meaningful microbiology findings. They are not observations of recovery in patients. The authors called for further safety, pharmacokinetic and in-vivo research before clinical use.

Why a culture result does not provide a human dose

Researchers can place an oil directly in contact with bacteria in a dish. An oral product must be absorbed and distributed through the body while remaining tolerable. A concentration that suppresses a culture may never be reached safely in the relevant tissues.

Culture models also cannot reproduce the full immune response, different causes of ongoing symptoms or the clinical complexity of a person who has already received antibiotics.

A separate 2019 study by Goc and colleagues investigated selected oils and fatty acids. Its leading findings concerned bay leaf and cassia oils and their components. It adds laboratory research, not clinical confirmation that oregano treats Lyme disease.

Does this explain persistent symptoms?

Finding antibiotic-tolerant bacteria in an experimental culture does not show that every person with persistent symptoms has an active infection of that kind. Nor does it show that an oregano supplement will address their symptoms.

CDC guidance describes antibiotic treatment for Lyme disease. Some people take longer to recover. Continuing symptoms deserve clinical reassessment, including consideration of other explanations and supportive care.

Do not substitute oregano oil for prescribed antibiotics or use a positive laboratory headline to decide on further antimicrobial treatment yourself.

Product and safety differences

Culinary oregano, concentrated essential oil and commercial supplements are different exposures. Product names do not guarantee identical amounts of carvacrol or other ingredients.

The LiverTox oregano review describes variable supplement preparations and limited clinical evidence. An absence of reported liver injury is not proof that a product is effective, suitable in pregnancy or free of other harms.

Discuss supplements with a pharmacist or clinician, especially alongside medicines. Do not swallow a bottle sold for aromatherapy or apply undiluted oil to a tick bite. Irritation is not evidence of infection being treated.

When to seek help

NHS advice is to seek medical assessment after a possible tick exposure if you develop a spreading rash or flu-like symptoms. The rash is not always a classic bullseye, and not everyone remembers a bite.

A photograph of a tick, including the one illustrating this article, cannot tell whether it carries Borrelia. Timely assessment matters more than trying to disinfect a bite with essential oil.

Evidence assessment

Not adequately tested in people; laboratory evidence. Oregano is a research lead. A safe, effective human treatment regimen and benefits for persistent symptoms have not been established by the studies reviewed here.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Lyme disease evidence overview
• Oregano oil profile

References

1. Feng J et al. (2017). Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Frontiers in Medicine 4:169.
2. Goc A et al. (2019). Anti-borreliae efficacy of selected organic oils and fatty acids. BMC Complementary and Alternative Medicine 19:40.
3. CDC. Treatment and intervention for Lyme disease.
4. LiverTox (2023). Oregano.
5. NHS. Lyme disease.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Wintergreen oil alone has not been shown to treat plantar fasciitis in the research identified here. Related pain-relief products and a small mixed-terpene trial offer indirect evidence, with important formulation and safety limits.

Why wintergreen appears in heel-pain advice

Wintergreen oil contains methyl salicylate, an ingredient used in some topical pain-relief products. A licensed or labelled product has a specified formulation. Its evidence cannot automatically be transferred to concentrated essential oil.

The methyl salicylate patch trial

Higashi and colleagues studied 208 people with mild to moderate muscle strain. Participants received a methyl salicylate and menthol patch or placebo for eight hours.

The active patch improved the accumulated pain-relief score more than placebo. No serious adverse events were reported during this short study. However, this was muscle strain, not plantar fasciitis, and the patch contained two active ingredients.

It therefore supports short-term pain relief from that product in the studied setting. It does not establish that wintergreen oil repairs the plantar fascia or improves walking over weeks.

A 2024 plantar fasciitis trial deserves attention

Burke and Baillie tested a mixture of phytoterpenes and essential oils in DMSO, a solvent affecting skin penetration. Among 62 participants, 25 of 32 receiving the active formulation reported at least an 85% reduction in total pain by day ten, compared with none of 30 receiving placebo.

This striking result is preliminary. The complex formulation cannot isolate a wintergreen effect. Follow-up was short, participants could notice different aromas, and the study did not measure structural healing of the fascia.

Two people in each group withdrew because they disliked the aroma; no adverse events were reported. A small, brief trial cannot exclude uncommon or delayed harms. Independent replication and longer follow-up are needed.

Do not recreate the DMSO mixture at home. Its findings are not a dosing guide for an essential-oil blend.

Concentrated oil has a different risk profile

MedlinePlus describes potentially serious methyl salicylate poisoning. Swallowing wintergreen oil can be dangerous. Keep it away from children and seek urgent poison or medical advice after suspected ingestion; do not induce vomiting.

Ask a pharmacist before using a salicylate-containing product if you take medicines, have an aspirin or salicylate allergy, or are pregnant. Follow the product label, including age restrictions. Do not assume that applying more will relieve more pain.

What helps guide day-to-day care?

NHS guidance recommends reducing aggravating activities, supportive footwear and suitable stretching. A pharmacist or physiotherapist can help you choose appropriate support and pain relief.

Arrange assessment if pain is severe, keeps returning or has not improved after two weeks of self-care. Tingling, loss of sensation or foot pain with diabetes also warrants medical advice.

Temporary comfort can be useful, but it should support a practical rehabilitation plan. Persistent heel pain needs a diagnosis rather than repeated use of stronger oils.

Evidence assessment

Not adequately tested; indirect evidence. The available trials concern a combination patch for another condition and a complex plantar-fasciitis formulation. Neither establishes wintergreen oil alone as an effective or suitably safe treatment.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Plantar fasciitis evidence overview
• Wintergreen oil profile

References

1. Higashi Y et al. (2010). Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain. Clinical Therapeutics.
2. Burke BE, Baillie JE (2024). Randomized placebo controlled trial of phytoterpenes in DMSO for the treatment of plantar fasciitis. Scientific Reports 14:17621. doi:10.1038/s41598-024-65979-1.
3. MedlinePlus. Methyl salicylate overdose.
4. NHS. Plantar fasciitis.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Tea tree oil can inhibit Candida in laboratory experiments, but reliable clinical evidence for treating vaginal thrush is lacking. A very small uncontrolled study used probiotics followed by a specialist suppository in some participants. It does not justify home vaginal use of essential oil.

What the preliminary human study found

Di Vito and colleagues recruited 13 women; nine completed treatment. All received probiotics first. Five of those nine subsequently tested negative for fungi. Participants who remained positive then received a formulated tea-tree suppository.

By the end, seven of nine tested negative, and symptoms were reported to have resolved. There was no randomised control group and tea tree was not tested independently of the preceding treatment.

The staged design, small sample and four losses to follow-up make attribution difficult. The investigators also distinguished fungal colonisation from overt infection. These results cannot supply a dependable cure rate for ordinary thrush.

A separate safety observation involved only five volunteers. Lack of reported problems in so few people cannot establish safety for repeated use or pregnancy.

Laboratory Candida research is not a patient trial

The team’s earlier 2015 work tested tea-tree suppositories against cultured Candida and vaginal probiotic organisms. It investigated antimicrobial activity outside the body.

Research using organisms collected from patients remains laboratory research if patients themselves are not treated and assessed. A concentration that inhibits yeast in a test does not establish a tolerable vaginal treatment.

The same distinction applies to a 2023 study testing tea tree against Candida isolates associated with pregnancy. Nystatin produced substantially larger inhibition zones than either tea tree concentration. The pregnancy connection describes where the organisms came from, not proof of safe treatment during pregnancy.

Why a home remedy adds uncertainty

A manufactured suppository has a defined formulation. Oil mixed into water, placed on a tampon or added to a carrier oil does not recreate it. Concentration and tissue exposure may be uneven.

NCCIH says tea tree should not be swallowed and can irritate skin. Evidence for some external skin conditions cannot be transferred to sensitive genital tissue.

Do not insert tea tree oil or oil-soaked tampons, douche with it or apply concentrated oil to the vulva. Burning after application is a reason to stop, not evidence that yeast is being killed.

Confirming and treating thrush

NHS guidance recommends antifungal treatment and assessment when the diagnosis is uncertain. Similar irritation can have other causes.

Seek advice for a first episode, recurrent symptoms, failed treatment, pregnancy or breastfeeding, or relevant conditions such as diabetes. A pharmacist can help with a previously diagnosed, recognisable episode.

Avoid fragranced washes and vaginal deodorants. Persistent symptoms deserve review rather than repeated experiments with stronger products.

Evidence assessment

Not adequately tested; limited human evidence for specialist products. The small uncontrolled study is a research lead. It does not establish effectiveness, a suitable home dose or protection from irritation.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Yeast infection evidence overview
• Tea tree oil profile
• Tea tree and athlete’s foot

References

1. Di Vito M et al. (2016). Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study. Medical Journal of Obstetrics and Gynecology 4:1090.
2. Di Vito M et al. (2015). In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota. Phytotherapy Research. doi:10.1002/ptr.5422.
3. Ervianti E et al. (2023). Comparison of tea tree oil 5%, tea tree oil 10%, and nystatin inhibition zones against vaginal Candida isolates in pregnancy. Journal of Infection in Developing Countries 17:353–358. doi:10.3855/jidc.16761.
4. NCCIH. Tea tree oil.
5. NHS. Thrush in men and women.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Lavender oil has laboratory findings relevant to eczema, but no convincing standalone treatment benefit was identified in people. A small essential-oil massage study found no added benefit over massage alone. Fragrance can also aggravate sensitive skin.

Why an encouraging headline can mislead

A 2024 paper described lavender as an atopic-dermatitis suppressant. Its experiments used a cultured human skin-cell model, not people being treated for eczema.

The researchers investigated Lavandula angustifolia oil and constituents including linalyl acetate. They found changes in a signalling pathway and reduced expression of artemin, a molecule relevant to itch.

Some laboratory sensitisation tests were reassuring for the particular preparation. Those tests cannot rule out allergy after repeated human use. The paper itself discusses differences between oils and the effect of oxidation.

Human cells in a dish remain laboratory evidence. They do not show whether a child’s sleep improves, whether a flare settles or whether a product is tolerated over months.

The small human massage study

Anderson and colleagues compared massage with and without essential oils in childhood eczema. Families selected mixtures from several oils, including spike lavender, while ordinary medical care continued.

Both groups improved, without a significant advantage from adding essential oils. The researchers reported deterioration during further treatment periods in the oil group and raised possible contact allergy as an explanation.

The study was small, relied partly on parental observations and did not isolate lavender. Spike lavender is also a different preparation from the L. angustifolia oil in the cell study. It therefore provides a caution about aromatherapy mixtures, rather than a definitive test of every lavender product.

Relaxation and eczema control are separate questions

Enjoying a scent or a calm bedtime routine is different from controlling skin inflammation. Studies of lavender for sleep cannot establish that applying it to eczema will repair the skin barrier.

A useful trial would compare a defined product with an appropriate control alongside normal care. It would measure eczema severity, itching, sleep, treatment use and reactions over a meaningful period. The studies above do not provide that evidence.

Contact allergy deserves attention

DermNet identifies people with atopic dermatitis as a group at greater risk of essential-oil contact allergy. Reactions may develop after exposure rather than immediately.

A home spot test cannot guarantee that repeated application is safe. If a new product makes the skin worse, stop using it and seek advice rather than increasing the amount.

Do not add lavender oil to a prescribed cream or apply it neat. A fragrance-free moisturiser that you tolerate offers a more straightforward way to support an existing skin-care plan.

What to do during a flare

NHS eczema care includes regular emollients and appropriate anti-inflammatory treatment. Ask for review when the plan is not controlling symptoms or sleep disruption.

Hot, painful, swollen or rapidly worsening eczema, pus, fluid-filled lesions or fever needs urgent GP or NHS 111 advice. Oils should not delay assessment of possible infection.

Evidence assessment

Not adequately tested; indirect evidence. The human mixture study found no extra benefit, while the standalone lavender work remains laboratory research. Neither supplies a proven home treatment.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Eczema evidence overview
• Lavender oil profile
• Coconut oil and eczema trials

References

1. Sato H et al. (2024). Aromatic oil from lavender as an atopic dermatitis suppressant. PLOS ONE 19:e0296408.
2. Anderson C, Lis-Balchin M, Kirk-Smith M (2000). Evaluation of massage with essential oils on childhood atopic eczema. Phytotherapy Research 14:452–456.
3. DermNet. Allergic contact dermatitis to essential oils.
4. NHS. Atopic eczema.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Myrrh mouthwash has been studied after dental procedures, but this does not establish myrrh essential oil as a toothache remedy. Some healing measures improved; pain results were less convincing. A painful tooth still needs its cause identified.

The extraction study did not treat an untreated toothache

Al Eid’s trial enrolled 40 healthy adults having simple tooth extractions. It compared a myrrh-resin preparation with saline mouthwash for seven days after the procedure.

The myrrh group had better swelling, tenderness and socket-size findings. However, the difference in reported pain was not statistically significant. Teeth with abscesses or other local pathology were excluded.

The report also gives inconsistent percentages for participants without pain in its table and narrative. That is another reason to avoid presenting the results as a precise pain-relief promise.

The preparation used ground resin in water, not distilled myrrh essential oil. The trial followed dental treatment and excluded infected teeth. Its findings cannot establish that oil applied at home treats decay, a dental abscess or an inflamed tooth nerve.

What the implant trial adds

A 2022 randomised study compared myrrh and chlorhexidine mouthwashes after implant placement in 35 patients. At one week, differences in pain, swelling, bleeding and redness were not statistically significant.

The authors reported favourable aspects of early healing with myrrh, but the small study cannot establish equivalence to chlorhexidine. Failing to find a difference is not the same as proving two treatments equally effective.

Both studies concern care after a procedure. Neither establishes a treatment for an untreated painful tooth, and neither supports substituting a bottle of essential oil for a dentist’s mouthwash instructions.

Why the form of myrrh matters

Resin, an extract, a formulated mouthwash and essential oil contain different proportions of substances. A product’s common plant name does not make these preparations interchangeable.

Laboratory antimicrobial findings would still leave practical questions about tolerable concentration, contact time and access to the source of infection. A rinse cannot repair damaged tooth structure.

Use only oral-care products appropriate for their stated purpose and follow professional advice. Do not put concentrated essential oil into a cavity, on gums or in an extraction socket. Do not copy a research recipe.

Getting help for the pain

The NHS advises seeing a dentist for toothache lasting more than two days, pain that does not settle with painkillers, or pain with fever, swelling or a bad taste.

A pharmacist can advise on suitable pain relief while you arrange care. If you cannot obtain urgent dental help, NHS 111 can direct you. A GP cannot provide the dental procedure needed.

Swelling around the eye or neck, or swelling affecting breathing, swallowing or speech, requires emergency care. Do not wait to see whether an oil helps.

Evidence assessment

Not adequately tested; indirect evidence for myrrh oil and toothache. Small mouthwash studies offer a reason to investigate postoperative healing. Their mixed endpoints and different preparations do not support an essential-oil analgesic claim.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Toothache evidence overview
• Myrrh oil profile
• Lavender and dental anxiety

References

1. Al Eid RA (2021). Efficacy of Commiphora myrrh mouthwash on early wound healing after tooth extraction: a randomized controlled trial. Saudi Dental Journal. PMID:33473242.
2. Ibraheem WI et al. (2022). Evaluating Soft Tissue Healing after Implant Placement Using Two Different Mouthwashes (Myrrh and Chlorhexidine Gluconate): A Randomized Control Trial. Medicina 58:1351.
3. NHS. Toothache.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: A small trial of a chamomile-pumpkin preparation reported improvement in psoriasis plaques. It does not establish that chamomile essential oil alone works. Laboratory research offers a possible explanation, but routine treatment and skin tolerability remain essential.

What was actually tested?

The most relevant human study used an oleogel, an oil-based gel containing chamomile and pumpkin seed oil. The preparation matters: a combined herbal product cannot tell us which ingredient helped.

Kolahdooz and colleagues enrolled 40 adults with mild to moderate plaque psoriasis. Matching plaques on each person received the active gel or placebo twice daily for four weeks. Thirty-seven participants completed the trial.

The average reduction in the plaque severity score was 4.09 points with the active gel and 0.48 with placebo. Thirteen of 37 treated plaques achieved marked to complete improvement, compared with none of the placebo-treated plaques.

Three participants withdrew after plaques on both sides worsened during the first week. The short follow-up, withdrawals and combined formulation limit confidence. This was not evidence of lasting remission, treatment of severe psoriasis or superiority to prescribed medicines.

Why the laboratory study is a different kind of evidence

Chen and colleagues studied German chamomile essential oil in 2024. Their work used cultured skin cells and mice with experimentally induced psoriasis-like inflammation.

Several inflammatory measures improved, although the reported mouse findings did not include a reduction in IL-17A. Human samples were used to study inflammatory markers; that did not make the experiment a treatment trial in patients.

The work helps researchers identify mechanisms worth testing. It leaves unanswered whether an acceptable skin preparation improves human psoriasis, what concentration is tolerable and whether benefit lasts.

Evidence	What it supports
Chamomile-pumpkin gel trial	A preliminary, product-specific improvement in plaques.
Essential oil in cells and mice	A research lead, without established patient benefit.
Bottled oil used at home	No equivalent treatment regimen established by these studies.

Could chamomile make the skin worse?

NCCIH notes that chamomile can cause allergic reactions, particularly in people allergic to related plants. It also highlights limited safety information in pregnancy and breastfeeding.

Essential oils can cause contact dermatitis. An itchy reaction may be mistaken for worsening psoriasis, encouraging further application of the product causing the problem.

Do not put concentrated oil on plaques or reproduce an experimental formulation. Discuss any proposed skin product with a pharmacist or dermatology team, especially when the skin is cracked or sore.

Where this leaves treatment

NHS psoriasis guidance describes moisturisers, prescribed topical treatments and specialist options. Treatment depends on the site, extent and effect on daily life. Joint pain or swelling also deserves assessment.

The practical question is whether a specified product adds worthwhile benefit to care you can use consistently. A promising small trial warrants better research; it does not justify abandoning a treatment plan that controls the disease.

Evidence assessment

Not adequately tested; indirect evidence for chamomile oil alone. The positive human result concerns a combined gel. No convincing standalone chamomile-oil clinical benefit was identified in this search.

How this review was researched

Research checked on 14 September 2026. Targeted web searches used the oil name, botanical or ingredient names, the condition and clinical-trial terms. We checked accessible primary reports, PubMed records and the guidance cited below. This is an editorial review, not a systematic review. Some full texts were inaccessible; absence from these searches does not prove that no study exists. Different preparations and laboratory results are identified explicitly.

Related reading

• Psoriasis evidence overview
• Chamomile oil profile
• Chamomile and eczema

References

1. Kolahdooz S et al. (2018). Evaluation of the efficacy of a topical chamomile-pumpkin oleogel for the treatment of plaque psoriasis: an intra-patient, double-blind, randomized clinical trial. Biomedical Research and Therapy. doi:10.15419/bmrat.v5i11.499.
2. Chen G et al. (2024). Essential Oil of Matricaria chamomilla Alleviate Psoriatic-Like Skin Inflammation by Inhibiting PI3K/Akt/mTOR and p38MAPK Signaling Pathway. Clinical, Cosmetic and Investigational Dermatology 17:59–77.
3. NCCIH. Chamomile: usefulness and safety.
4. DermNet. Allergic contact dermatitis to essential oils.
5. NHS. Psoriasis.

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Lavender scent may help reduce short-term anxiety around a dental visit, but results vary and many trials have weak controls. It does not numb a tooth, replace local anaesthetic or establish a treatment for persistent dental phobia.

A calmer appointment is different from treating pain

Dental anxiety ranges from mild nervousness to fear that prevents someone seeking care. Research about anxiety immediately before a procedure does not necessarily tell us how to help a person who has avoided the dentist for years.

Lavender aromatherapy is usually studied as an addition to dental care. Participants still receive the relevant dental treatment and clinical pain control. Its possible role is helping with distress, not making an untreated tooth problem safe to ignore.

The reviews report benefit, but disagree about certainty

A lavender-specific systematic review and meta-analysis included six studies and found lower anxiety scores with lavender. Its authors rated the pooled anxiety evidence highly. That positive assessment deserves acknowledgement rather than being omitted because other reviews are more cautious.

A broader review of dental aromatherapy included 17 studies and judged the evidence low or very low in certainty, with substantial concerns about bias. It found more encouraging comparisons against usual care than against an active alternative such as music.

These reviews used different sets of studies and appraisal decisions. A small statistical inconsistency between pooled results is not the only question: masking, comparison treatments and the reliability of outcome measurement also affect confidence.

A 2026 scoping review mapped 20 trials involving 3,460 participants. Anxiety findings were often favourable, while pain findings were generally less convincing. Only one trial used an olfactory control. A scoping review maps the field; it does not by itself establish a precise treatment effect.

Evidence	What it suggests	Important limit
Immediate anxiety	Often lower in aromatherapy groups	Many comparisons cannot conceal the scent
Pain and local anaesthesia	Not consistently improved	Lavender does not replace dental pain control
Persistent dental phobia	Not established by brief appointment studies	May need a tailored behavioural and clinical plan

Recent trials add detail rather than a universal answer

A randomised wisdom-tooth surgery trial reported favourable changes in some physiological and treatment measures with lavender, including cortisol and the number of anaesthetic cartridges used. Every such result belongs within the study’s clinical setting. It does not mean anaesthetic was unnecessary or that a patient should request less than needed.

A 100-child trial compared lavender, chamomile, peppermint and a control condition during dental care. Lavender and chamomile performed better on a child-friendly anxiety measure. The difficulty of concealing a distinctive smell and the specific age group limit generalisation.

Importantly, a 72-person root-canal trial comparing lavender, music, both and a control did not find significant between-group differences in blood pressure or heart rate. Those physiological outcomes are not identical to self-reported anxiety, but the negative comparisons should remain visible.

A 20-person dental-office pilot reported lower anxiety with lavender without corresponding changes in its EEG and heart-rate-variability measures. A small experiment in healthy participants is useful exploratory work, not a definitive trial in people with severe dental phobia.

Why an unscented comparison can be a weak test

Someone who notices lavender may expect to relax, while someone in an unscented room knows that they did not receive the aroma. Extra attention and the treatment setting may also differ. This does not make a person’s reduced anxiety unreal, but it makes the specific contribution of lavender harder to measure.

A more informative study would compare equally plausible scents or another calming intervention, keep staff attention similar, and measure whether the effect changes treatment completion or future attendance. Brief anxiety scores alone cannot establish those longer-term benefits.

How to approach an anxious dental visit

Tell the dentist about the fear before treatment starts. Agree how you can signal for a pause and discuss available pain control and anxiety support. If a scent helps you, ask whether it is suitable in that practice rather than bringing a diffuser into a shared clinical space.

NHS breathing exercises for stress provide a simple non-drug approach that some people find useful. Such strategies can accompany a dental plan, but should not be used to postpone treatment of swelling, infection or persistent pain.

NCCIH describes possible lavender adverse effects and safety uncertainties. Do not put essential oil onto a painful tooth or gum, swallow it, or apply it inside a child’s mask without professional agreement. A pleasant room scent and direct exposure of mouth or skin are different interventions.

Our assessment

Finding: promising short-term anxiety benefit. Evidence strength: limited human evidence. Positive trials justify interest, while control problems and inconsistent physiological findings limit certainty. Lavender is best discussed as an optional comfort measure alongside appropriate dental care.

How this review was researched

Research checked on 14 September 2026. We searched PubMed for the named preparation and outcome, read the retrieved study abstracts and relevant reviews, and checked the linked health guidance. This is an editorial review, not an exhaustive systematic review. We identify studies of mixtures, other preparations and different patient groups rather than treating them as interchangeable evidence.

Related reading

• Lavender oil profile
• Essential oils and anxiety
• Toothache: evidence and safer care
• Lavender and broader anxiety claims

References

1. Is aromatherapy associated with patient's dental anxiety levels? A systematic review and meta-analysis.
2. Efficacy of aromatherapy on dental anxiety: A systematic review of randomised and quasi-randomised controlled trials.
3. Aromatherapy with essential oils to reduce anxiety, pain, and discomfort during in-office dental procedures: A scoping review.
4. Aromatherapy with lavender essential oil for the control of dental anxiety in patients undergoing dental surgery: A triple-blind randomized clinical trial.
5. The effects of lavender, chamomile and peppermint inhalation aromatherapy on dental anxiety in children: A randomized controlled trial.
6. Effects of Music and Aromatherapy on Blood Pressure and Heart Rate Among Endodontic Patients: A Randomized Clinical Trial.
7. Scents modulate anxiety levels, but electroencephalographic and electrocardiographic assessments could diverge from subjective reports: a pilot study.
8. NHS: Breathing exercises for stress
9. NCCIH: Lavender

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Tea tree ingredients have been studied in specialist eyelid products for Demodex-related blepharitis, but the trial evidence remains uncertain. This is not a reason to put bottled tea tree oil in or around the eyes. Diagnosis and a suitable eyelid-care plan come first.

Blepharitis is not the same as conjunctivitis

Blepharitis affects the eyelid margins and can cause soreness, crusting and irritation. Demodex mites may be involved in some cases, but eyelid symptoms can have several causes. A treatment directed at mites is not automatically appropriate for every red or uncomfortable eye.

NHS guidance on blepharitis describes regular eyelid hygiene and advice from a pharmacist or clinician. Eye pain, changes in vision or a very red eye need urgent assessment. Our conjunctivitis review discusses a different condition; the two should not be treated as interchangeable oil claims.

What the tea tree trials suggest

A randomised eyelid-scrub study assigned people with Demodex infestation to tea tree or control scrubs. It reported a reduction in mite counts in the tea tree group, while symptom scores improved in both groups. Improvement after treatment is not enough by itself to establish which ingredient caused it.

The Cochrane review of tea tree oil for Demodex blepharitis brought together six randomised studies involving 562 participants. Concentrations and regimens varied considerably. The reviewers found the evidence too uncertain to establish effectiveness confidently and identified substantial problems with bias and outcome reporting.

Three included studies reported symptom scores without showing a clear difference between groups. Irritation was reported in some participants. Counting fewer mites and feeling better are related questions, but neither outcome should be substituted for the other when describing the results.

Evidence	What it suggests	Important limit
Demodex counts	Some studies report reductions	Very uncertain evidence across differing regimens
Patient discomfort	Symptoms sometimes improve	Control groups can also improve
Bottled essential oil near the eye	Not established by eyelid-product research	Potential irritation and eye exposure

Later studies do not all isolate tea tree oil

A 49-person trial in seborrhoeic blepharitis compared baby shampoo with eyelid swabs containing tea tree and chamomile ingredients. Symptoms favoured the swabs, while mite counts fell similarly in both groups. This was a combined product and a particular blepharitis population, not a test of tea tree alone for all eye irritation.

In an 81-person Demodex study, both groups used a tea tree shampoo while one group also received a mechanical eyelid treatment. The added procedure improved some outcomes. Because both groups received tea tree, the trial cannot establish its independent benefit over a tea-tree-free regimen.

A comparison of okra and tea tree eyelid patches reported improvement with both approaches without a significant difference in the main symptom and mite outcomes. An active-comparator study of that kind does not resolve how either compares with an otherwise equivalent inert product.

Why the formulation matters for safety

A study of commercial eyelid cleansers in 30 healthy people found different short-term discomfort and ocular-surface responses between products. It was a brief tolerability experiment, not a long-term treatment trial. Its practical lesson is that finished preparations cannot be treated as interchangeable just because their labels mention similar ingredients.

A laboratory study of terpinen-4-ol found toxic effects on cultured human meibomian-gland cells. Those glands help maintain the tear film. This is a reason for careful formulation and clinical research, but cell exposure does not measure the rate of harm from a correctly used eyelid product in patients.

NCCIH notes that tea tree oil can irritate skin and must not be swallowed. Eye-area use needs particular care. Do not make a home dilution, add drops to an eye wash or put oil into the eye. If oil gets into an eye, rinse promptly and obtain urgent advice if pain, redness or vision problems persist.

What to discuss with an optometrist or clinician

Ask whether the symptoms actually suggest Demodex-related disease, which eyelid-care product is appropriate, and what to do if it stings or makes symptoms worse. A prescribed or recommended regimen should specify the product and how it is used. The trial concentrations described in papers are not a home recipe.

Persistent symptoms deserve reassessment rather than increasingly strong oil applications. The research does not show that a tea tree diffuser treats eyelid disease or that a general-purpose essential-oil bottle can replace established eye care.

Our assessment

Finding: uncertain or mixed benefit. Evidence strength: limited human evidence. There is clinical research on specialised products, but important uncertainty remains about symptoms, mite outcomes and tolerability. That narrow finding should stay separate from unsafe general claims about essential oils for eyes.

How this review was researched

Research checked on 14 September 2026. We searched PubMed for the named preparation and outcome, read the retrieved study abstracts and relevant reviews, and checked the linked health guidance. This is an editorial review, not an exhaustive systematic review. We identify studies of mixtures, other preparations and different patient groups rather than treating them as interchangeable evidence.

Related reading

• Tea tree oil profile
• Conjunctivitis and essential oils
• Essential oil safety

References

1. Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis.
2. Tea tree oil for Demodex blepharitis.
3. Swabs Containing Tea Tree Oil and Chamomile Oil Versus Baby Shampoo in Patients With Seborrheic Blepharitis: A Double-Blind Randomized Clinical Trial.
4. Role of Blepharoexfoliation in Demodex Blepharitis: A Randomized Comparative Study.
5. Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil.
6. Short-term tolerability of commercial eyelid cleansers: A randomised crossover study.
7. Effects of Terpinen-4-ol on Meibomian Gland Epithelial Cells In Vitro.
8. NHS: Blepharitis
9. NCCIH: Tea tree oil

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Small trials suggest that lavender aromatherapy may reduce reported pain or distress during labour. It can be considered a comfort option with the maternity team, but it is not a proven way to shorten labour, induce birth or replace the pain relief you want.

Comfort is a useful outcome, but a specific one

Labour pain is influenced by contractions, fatigue, fear, support and the surroundings. A pleasant scent may help some people feel calmer. That experience can matter even when it does not change the course of labour.

The research question is whether a defined lavender intervention improves outcomes compared with otherwise similar care. It is harder to answer than asking whether people feel better after a supportive massage or a quieter period in the birth room.

What the randomised trials found

A trial of 120 first-time mothers compared lavender inhalation with a distilled-water control at several stages of labour. Reported pain favoured lavender. However, the duration of the active phase and second stage did not differ between groups.

A 121-person trial compared lavender inhalation, lavender massage and a control group. Pain findings favoured the aromatherapy interventions at measured stages. The massage arm cannot separate the oil from touch, attention and the massage itself.

In a 150-person comparison of TENS, lavender and a control group, both interventions reduced reported pain, with TENS performing better than lavender. Labour duration and the reported maternal and neonatal outcomes did not differ significantly.

These are encouraging symptom findings. They are not proof of equal safety across all pregnancies: small trials cannot reliably exclude uncommon complications. Nor does a favourable comparison with a control group mean that lavender matches epidural or other established analgesia.

Evidence	What it suggests	Important limit
Reported labour pain	Several small trials favour lavender	Scent is difficult to conceal; care and expectations may differ
Length of labour	Key trials did not show a clear reduction	Do not describe lavender as a labour accelerator
Safety across pregnancy	Brief trials report limited information	Not enough to establish safety for every pregnancy

How the reviews change our confidence

A review of lavender and childbirth pain pooled favourable findings from Iranian studies. Pooling provides a broader view, but differences in lavender preparations, delivery methods and study quality limit how confidently the result transfers to another maternity setting.

A systematic review of obstetric aromatherapy also found encouraging pain and anxiety results across several oils. That wider evidence cannot all be credited to lavender. Reviews may include some of the same trials, so their positive conclusions are not independent replications.

Because lavender has an obvious scent, participants often know which intervention they receive. Pain scores remain meaningful, but expectations and extra support can contribute to a difference. Larger studies with comparable care and clear adverse-event reporting would help establish the size and reliability of any benefit.

Studies after birth answer another question

A trial after caesarean birth compared lavender, rose and placebo inhalation in 90 women and reported favourable pain and anxiety findings. This concerns recovery after surgery, alongside clinical care. It does not show that lavender can replace anaesthesia or medicines during a caesarean birth.

A small study after episiotomy investigated postpartum discomfort. It should not be counted as another trial of pain during labour, and it does not justify applying essential oils to a healing perineal wound at home.

Planning pain relief with the maternity team

NHS guidance on pain relief in labour describes a range of options, including support, breathing approaches, gas and air, medicines and epidural analgesia. Your preferences can change during labour. Trying a comfort measure does not commit you to managing without other relief.

If lavender appeals to you, discuss it with the midwife beforehand and follow the maternity unit’s policy. Other people in a shared room may find scents unpleasant or irritating. Stop if the smell makes you nauseated, dizzy or uncomfortable.

NCCIH says little is known about lavender safety during pregnancy and breastfeeding. Do not swallow essential oil, apply concentrated oil, add it to intimate tissues or use it to try to start labour. People with a complicated pregnancy need advice specific to their circumstances.

Our assessment

Finding: promising short-term comfort benefit. Evidence strength: limited human evidence. Lavender may be an optional addition to supportive maternity care. The evidence does not establish faster birth or a substitute for appropriate obstetric care and effective analgesia.

How this review was researched

Research checked on 14 September 2026. We searched PubMed for the named preparation and outcome, read the retrieved study abstracts and relevant reviews, and checked the linked health guidance. This is an editorial review, not an exhaustive systematic review. We identify studies of mixtures, other preparations and different patient groups rather than treating them as interchangeable evidence.

Related reading

• Lavender oil profile
• Aromatherapy and relaxation
• Essential oil safety

References

1. The effect of aromatherapy with lavender essence on severity of labor pain and duration of labor in primiparous women.
2. Determining the effect of inhalation and lavender essential oil massage therapy on the severity of perceived labor pain in primiparous women: A randomized controlled trial.
3. Comparative study of transcutaneous electrical nerve stimulation, the aromatherapy of Lavandula and physiologic delivery without medication on the neonatal and maternal outcome of patients.
4. The Effect of Lavender (Lavandula stoechas L.) on Reducing Labor Pain: A Systematic Review and Meta-Analysis.
5. Is aromatherapy effective in obstetrics? A systematic review and meta-analysis.
6. Compare the effect of aromatherapy using lavender and Damask rose essential oils on the level of anxiety and severity of pain following C-section: A double-blinded randomized clinical trial.
7. Episiotomy pain relief: Use of Lavender oil essence in primiparous Iranian women.
8. NHS: Pain relief in labour
9. NCCIH: Lavender

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.

HealthWatchlist verdict: Topical coconut oil has encouraging clinical evidence for supporting the fragile skin of premature babies under neonatal care. That does not make it a universal treatment for baby rashes or prove that it prevents serious infection. Follow the baby’s clinical team’s skin-care plan.

This is a moisturising oil, not aromatherapy

Coconut oil is a fatty oil, rather than a concentrated volatile essential oil. Its skin-care research concerns moisturising and supporting the skin barrier. It should not be grouped with lavender or tea tree drops when deciding what to put on a baby.

The most relevant neonatal research involves premature babies, whose skin barrier is less mature. Those infants have different care needs from healthy full-term newborns. A hospital study is not a home-treatment instruction for any baby with dry or red skin.

What the skin-barrier trials found

A randomised trial involving 74 very-low-birth-weight infants compared coconut oil application with standard care. Over the first week, the oil group lost less water through the skin and had better skin-condition scores. The study did not use massage as part of the oil intervention.

A trial of 72 babies born before 30 weeks compared routine care with added coconut oil over 21 days. Skin condition was maintained better in the coconut-oil group. However, common neonatal outcomes, including sepsis and mortality, did not differ between groups.

This second study was open-label, meaning caregivers knew which treatment was being given. Its size was also insufficient to settle uncommon but serious outcomes. The positive skin finding and the absence of a demonstrated sepsis benefit both belong in the conclusion.

A more recent 66-infant trial compared coconut oil, sunflower seed oil and a control group. It reported better skin scores and weight at one month after discharge in both oil groups. The small sample and relatively mature infants limit what it tells us about the most premature babies.

Evidence	What it suggests	Important limit
Skin condition and water loss	Several trials report favourable results	Small studies with different neonatal populations
Serious infection	Some pooled findings are encouraging	Certainty is limited; direct trials are not uniformly positive
An unexplained baby rash	These trials do not establish treatment	Diagnosis and age-appropriate care remain necessary

Infection prevention is still a separate question

A 2019 review of seven coconut-oil trials reported fewer hospital-acquired bloodstream infections in a pooled analysis of two studies. The review graded the evidence as low to moderate depending on the outcome and called for larger trials, particularly in very premature babies.

The 2021 Cochrane review of topical emollients assessed a wider range of products. Plant and vegetable oils may reduce invasive infection, but the certainty was low and mortality showed little or no difference. Results across several oils cannot all be attributed to coconut oil.

A 2026 trial protocol describes a much larger study of coconut oil and late-onset sepsis in babies born before 28 weeks. A protocol explains the planned investigation; it is not a completed positive result. The question remains important precisely because skin improvement does not automatically prove infection prevention.

Why adult dry-skin and childhood eczema studies are different

A controlled trial in mild to moderate dry skin compared virgin coconut oil with mineral oil as a moisturiser. It supports considering coconut oil within moisturising research, but it cannot decide neonatal skin care.

The childhood eczema trial also involved a defined condition and a different age group. Our coconut oil and eczema review examines those results separately. Neither study proves a remedy for nappy rash, infection, allergy or every patch of redness on a newborn.

What this means for parents

For a premature baby, ask the neonatal team which product, if any, belongs in the care plan. They can take account of gestational age, skin integrity, lines and dressings, and the unit’s infection-control procedures. Do not replace prescribed care with a kitchen product or add essential oils to coconut oil.

For routine bathing, NHS guidance allows just water or a cleanser suitable for babies and says to check that any oils or lotions are suitable for babies. A study in a neonatal unit does not mean every healthy newborn needs an oil routine. Seek advice from your midwife or health visitor about a rash or persistent skin problem.

The absence of reported irritation in a small trial cannot guarantee that every product suits every baby. Stop a new topical product if the skin worsens and seek professional advice. The studies also do not support putting oil into a baby’s mouth or using it as an infection treatment.

Our assessment

Finding: promising benefit for skin condition in neonatal care. Evidence strength: limited human evidence. Coconut oil has a real clinical research base. Its useful role is narrower than claims that it cures baby rashes or reliably prevents serious infection.

How this review was researched

Research checked on 14 September 2026. We searched PubMed for the named preparation and outcome, read the retrieved study abstracts and relevant reviews, and checked the linked health guidance. This is an editorial review, not an exhaustive systematic review. We identify studies of mixtures, other preparations and different patient groups rather than treating them as interchangeable evidence.

Related reading

• Coconut oil profile
• Coconut oil and eczema trials
• Rashes and essential-oil claims
• Essential oil safety

References

1. Topical Oil Application and Trans-Epidermal Water Loss in Preterm Very Low Birth Weight Infants-A Randomized Trial.
2. Topical Coconut Oil in Very Preterm Infants: An Open-Label Randomised Controlled Trial.
3. Comparison of Coconut and Sunflower Seed Oils in Improving the Skin Integrity and Weight Gain of Infants in the Neonatal ICU.
4. Topical application of coconut oil to the skin of preterm infants: a systematic review.
5. Topical emollient for preventing infection in preterm infants.
6. Can topical coconut oil reduce late-onset sepsis in extremely preterm infants? A pragmatic cluster-randomised controlled trial protocol.
7. A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis.
8. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial.
9. NHS: Washing and bathing your baby

Editor: John Hamlen. This article has not been independently reviewed by a clinician. See our editorial policy, evidence method and corrections policy.